Hospital Louis Pradel, FR

Lyon

0 studies enrolling now · 1 studies all time

What they study most

NRG1 Fusion, NSCLC Harboring NRG1 Fusion, Pancreatic Cancer Harboring NRG1 Fusion, Solid Tumours Harboring NRG1 Fusion

Studies at this site

• A Study of Zenocutuzumab (MCLA-128) in Patients With Solid Tumors Harboring an NRG1 Fusion (eNRGy) — Running, not enrolling